Description
Dihexa is a small angiotensin IV-derived peptide developed at Washington State University, designed for metabolic stability and blood-brain-barrier penetration.
Its research literature centres on potentiation of hepatocyte growth factor (HGF) signalling through c-Met, with synaptogenesis and cognitive endpoints in rodent models. It is an early-stage experimental compound.
Format & handling
Supplied as a lyophilized powder in a sealed, batch-stamped vial. Store sealed at −20 °C protected from light. For laboratory work, reconstitute with bacteriostatic water shortly before use and refrigerate any working solution at 2–8 °C.
For laboratory research use only — not for human or veterinary use. The summary above describes published research for scientific context and makes no claims about this product.
